Expanding the Spectrum of Endocrine Abnormalities Associated with SOX11-related Disorders.

Bang Sun,Maria I Stamou,Sara L Stockman,Mark B Campbell,Lacey Plummer,Kathryn B Salnikov,Leman Damla Kotan,A Kemal Topaloglu,Fuki M Hisama,Erica E Davis,Stephanie B Seminara,Ravikumar Balasubramanian
{"title":"Expanding the Spectrum of Endocrine Abnormalities Associated with SOX11-related Disorders.","authors":"Bang Sun,Maria I Stamou,Sara L Stockman,Mark B Campbell,Lacey Plummer,Kathryn B Salnikov,Leman Damla Kotan,A Kemal Topaloglu,Fuki M Hisama,Erica E Davis,Stephanie B Seminara,Ravikumar Balasubramanian","doi":"10.1210/clinem/dgae620","DOIUrl":null,"url":null,"abstract":"CONTEXT\r\nSOX11 variants cause Coffin-Siris Syndrome (CSS), characterized by developmental delay, hypogonadotropic hypogonadism (HH), skeletal and facial defects.\r\n\r\nOBJECTIVE\r\nTo examine the contribution of SOX11 variants to the pathogenesis of Idiopathic Hypogonadotropic Hypogonadism (IHH), a disorder caused by hypothalamic GnRH deficiency.\r\n\r\nSETTING\r\nThe Reproductive Endocrine Unit and the Pediatric Endocrinology Division, Massachusetts General Hospital.\r\n\r\nPATIENTS OR OTHER PARTICIPANTS\r\nA cohort of 1810 unrelated IHH probands.\r\n\r\nINTERVENTIONS\r\nExome sequencing data from the entire cohort were examined for SOX11 rare single nucleotide variants (SNVs) [minor allele frequency in the gnomAD database <0.1%]. Rare SOX11 variant association testing was performed between the IHH and gnomAD population. Phenotyping of individuals harboring pathogenic/likely pathogenic SNVs (determined by the ACMG criteria) was performed.\r\n\r\nMAIN OUTCOMES/RESULTS\r\nFour pathogenic SOX11 SNVs were identified in 5 IHH probands. The IHH cohort was enriched for SOX11 protein truncating SNVs (frameshift/nonsense) across the entire protein (2 SNVs in 3 IHH cases [p.S303X (de-novo); p.S345Afs*13]; p 0.0004981) and for SOX11 missense SNVs within the SOX11-high-mobility group (HMG) domain (2 SNVs in 2 IHH cases p.G84D[de-novo]; p.P114S; p=0.00313922). The phenotypic spectrum of SOX11 variant carriers revealed additional endocrine defects including anosmic and normosmic forms of IHH, growth-hormone deficiency, pituitary and hypothalamic structural defects, and hypothyroidism. A pathogenic SOX11 SNV was also identified in a patient with functional HH (FHH, p.R100Q). CSS-associated features were present in 4/5 probands.\r\n\r\nCONCLUSIONS\r\nDeleterious SOX11 variants cause IHH and other pituitary hormone deficiencies, suggesting that the human SOX11-associated disorder may stem from both hypothalamic and pituitary level defects.","PeriodicalId":22632,"journal":{"name":"The Journal of Clinical Endocrinology & Metabolism","volume":"49 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/clinem/dgae620","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

CONTEXT SOX11 variants cause Coffin-Siris Syndrome (CSS), characterized by developmental delay, hypogonadotropic hypogonadism (HH), skeletal and facial defects. OBJECTIVE To examine the contribution of SOX11 variants to the pathogenesis of Idiopathic Hypogonadotropic Hypogonadism (IHH), a disorder caused by hypothalamic GnRH deficiency. SETTING The Reproductive Endocrine Unit and the Pediatric Endocrinology Division, Massachusetts General Hospital. PATIENTS OR OTHER PARTICIPANTS A cohort of 1810 unrelated IHH probands. INTERVENTIONS Exome sequencing data from the entire cohort were examined for SOX11 rare single nucleotide variants (SNVs) [minor allele frequency in the gnomAD database <0.1%]. Rare SOX11 variant association testing was performed between the IHH and gnomAD population. Phenotyping of individuals harboring pathogenic/likely pathogenic SNVs (determined by the ACMG criteria) was performed. MAIN OUTCOMES/RESULTS Four pathogenic SOX11 SNVs were identified in 5 IHH probands. The IHH cohort was enriched for SOX11 protein truncating SNVs (frameshift/nonsense) across the entire protein (2 SNVs in 3 IHH cases [p.S303X (de-novo); p.S345Afs*13]; p 0.0004981) and for SOX11 missense SNVs within the SOX11-high-mobility group (HMG) domain (2 SNVs in 2 IHH cases p.G84D[de-novo]; p.P114S; p=0.00313922). The phenotypic spectrum of SOX11 variant carriers revealed additional endocrine defects including anosmic and normosmic forms of IHH, growth-hormone deficiency, pituitary and hypothalamic structural defects, and hypothyroidism. A pathogenic SOX11 SNV was also identified in a patient with functional HH (FHH, p.R100Q). CSS-associated features were present in 4/5 probands. CONCLUSIONS Deleterious SOX11 variants cause IHH and other pituitary hormone deficiencies, suggesting that the human SOX11-associated disorder may stem from both hypothalamic and pituitary level defects.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
扩大与 SOX11 相关疾病有关的内分泌异常范围。
目的研究SOX11变体对特发性性腺功能减退症(IHH)发病机制的影响,IHH是一种由下丘脑GnRH缺乏引起的疾病。设置马萨诸塞州总医院生殖内分泌科和儿科内分泌科.患者或其他参与者1810名无血缘关系的IHH疑似患者队列.干预对整个队列的SOX11罕见单核苷酸变异(SNV)[gnomAD数据库中的小等位基因频率小于0.1%]的Exome测序数据进行检查。在 IHH 和 gnomAD 群体中进行了罕见 SOX11 变异关联测试。对携带致病/可能致病 SNV(根据 ACMG 标准确定)的个体进行了表型分析。主要结果/结果在 5 名 IHH 患者中发现了 4 个致病 SOX11 SNV。在整个蛋白质中,IHH 组群富含 SOX11 蛋白截短 SNV(移帧/无义)(3 个 IHH 病例中有 2 个 SNV [p.S303X (de-novo); p. S345Afs*13] )。S345Afs*13];p 0.0004981)和 SOX11 高移动性组(HMG)结构域内的 SOX11 错义 SNV(2 个 IHH 病例中的 2 个 SNV p.G84D[去新];p.P114S;p=0.00313922)。SOX11变异携带者的表型谱显示出其他内分泌缺陷,包括IHH无症型和正常型、生长激素缺乏、垂体和下丘脑结构缺陷以及甲状腺功能减退。在一名功能性 HH(FHH,p.R100Q)患者身上还发现了致病的 SOX11 SNV。结论畸变的SOX11变体会导致IHH和其他垂体激素缺乏症,这表明人类SOX11相关疾病可能源于下丘脑和垂体水平的缺陷。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Efficacy and safety of targeted therapy for radioiodine-refractory differentiated thyroid cancer: a meta-analysis. Treatment Preferences in Patients with Hypothyroidism: an Analysis of Eleven Randomized Controlled Trials. Metabolomics: A Promising Tool in the Prevention, Diagnosis, and Treatment of Obesity. Association between papillary thyroid cancer and primary aldosteronism in individuals with hypertension. The changing treatment paradigm in prolactinoma - a prospective series of 100 consecutive neurosurgical cases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1